Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein

Jeff Chen, Michael P. Hutchens, Wayne T. Nicholson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Addition of carvedilol (a P-glycoprotein inhibitor) to the cyclosporine (a P-glycoprotein substrate) resulted in increased cyclosporine levels and cyclosporine toxicity.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages641-644
Number of pages4
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein'. Together they form a unique fingerprint.

  • Cite this

    Chen, J., Hutchens, M. P., & Nicholson, W. T. (2015). Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 641-644). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_142